Late in an investment process, the question the reviewing party places on the table is frequently the one the company has never put to itself: not the percentages appearing in the share register today, but where those same percentages land in a future where every contingent right that has been granted has been triggered. The company side is rarely caught entirely unprepared — the numbers can be assembled in some fashion — yet the assembled figure fails to reconcile with the cap table file already sitting in the data room. The discrepancy is not an error of arithmetic but an artefact of how the record is kept: in most companies the cap table is maintained as a statement of current position, whereas the party conducting the review reads it as an inventory of obligations. Until those two readings converge in a single document, the difference between them propagates quietly through everything that follows.
The pattern sharpens as the company grows. At the first financing round the cap table is clean and can be held in memory — founders, a handful of angels, perhaps a pool announced in intention but not yet allocated. Over the following two years the table accumulates convertible instruments, bridge notes carrying different caps and discount rates, equity promised verbally to key hires but never documented, a warrant issued to a supplier as part of a commercial settlement, and the anti-dilution protection negotiated by the investor in the preceding round. Each of these, taken in its own context, represents a reasonable and often necessary decision; the difficulty lies not in the decisions themselves but in the absence of any single place where they are brought together.
The mechanism operating underneath is not accounting but the economics of attention. A contingent right, at the moment it is granted, moves no cash, opens no line on the balance sheet, and generates no row in monthly reporting; the organisation's measurement reflexes therefore never register it. A commitment whose present cost is zero and whose future cost is indeterminate is an unusually attractive instrument from the standpoint of near-term decision comfort — promising equity instead of paying cash is a rational choice for a company operating against a constrained resource base. That rationality expires the moment the condition changes, which is to say the moment the company enters institutional diligence, because from that point forward the aggregate of the same commitments ceases to function as flexibility and becomes a stack of obligations requiring a price.
The first thing the review establishes is whether the structure formally exists at all: whether a fully diluted schedule is an instrument genuinely built and used inside the company, or a calculation produced only on request. The second is the degree of documentation — board and shareholder approval of the option plan, the execution status of grant letters, the commencement dates governing vesting schedules, the caps and discounts attaching to convertible instruments, and whether the anti-dilution formula operates on a full-ratchet or a broad-based weighted-average basis. The gap between these two layers is among the most frequently recorded findings in diligence: the structure exists, the decisions were taken, but the record of those decisions sits scattered across a founder's email archive rather than consolidated into a single approved document.
The third layer is practice, and it is ordinarily the weakest. The existence of an option plan and the consistent operation of that plan in daily administration are distinct propositions; whether unvested shares held by a departing employee return to the pool, whether the exercise window on vested shares is actually tracked, and whether new grants remain within the authorised plan ceiling are the points at which the distinction becomes measurable. The fourth layer is measurement: whether dilution is monitored as a standing indicator, or calculated only as a financing round approaches. The fifth is ownership — who updates the schedule, which approval a grant above a given threshold requires, and to whom the reconciliation is reported. The sixth is continuity: whether the same exercise can be performed to the same standard of accuracy when the individual carrying the institutional knowledge is not available.
The sum of these six layers translates directly into valuation language, and the channel of translation is usually something other than price. Where the reviewing party cannot independently verify the fully diluted schedule, the risk is absorbed by tightening deal structure rather than by marking down price per share: independent verification of the cap table is imposed as a condition precedent, a dilution-specific representation is expanded within the warranty package, escrow percentages and holdback periods move upward, and in certain cases an additional vesting schedule is attached to founder shares. What these instruments share is that none of them presents as an outright reduction in headline value, while each materially alters the timing and the certainty of the cash the founders ultimately receive.
The second channel is the timetable. An unverifiable cap table adds a further round of legal review to the closing process; every missing grant letter, every unexecuted amendment to the shareholders' agreement, and every vesting commencement date of uncertain provenance generates a distinct remediation item, and such items typically advance in sequence, each waiting on the one before it, rather than in parallel. An extended closing produces more than legal cost; it redistributes negotiating leverage, since time pressure almost invariably operates against the party seeking capital. The third channel is discussed less often but proves the most durable: the impression that the cap table resides in a founder's recollection is read as an indicator of the company's broader institutional maturity, and it causes findings under every other diligence heading to be interpreted with greater caution.
The mechanism that neutralises this tendency is design rather than individual diligence. An effective structure comprises three distinct components: first, a decision register in which every contingent right is recorded at the moment it is granted rather than at the moment it is exercised; second, an authority threshold defining in advance which body must approve a grant of a given magnitude; and third, a review cycle in which the fully diluted schedule is reconciled against the legal records on a defined rhythm, typically quarterly. Where these three components operate together, dilution ceases to be a figure computed under pressure in advance of a round and becomes a management variable under continuous observation.
BEIREK's intervention in this area begins not with recalculating the schedule but with building the decision chain standing behind it. Every contingent right granted since incorporation — option allocations, convertible instruments, warrants, performance-linked equity commitments, and promises that were only ever verbal — is consolidated into a single inventory, each entry tied to the document on which it rests, with those lacking documentation held in a separate open-items list; that list constitutes the work required to be closed before the data room opens. The fully diluted schedule is then constructed not as a single case but as a scenario set reflecting different combinations of triggering events, making explicit the price level at which the anti-dilution formulas would engage in a subsequent round.
The second stage concerns rhythm. Authority thresholds are reduced to writing, a workflow is established in which grant decisions enter the record at the point of proposal rather than at the point of approval, and the quarterly reconciliation is calendared in a form that seats finance and legal at the same table. The purpose of this rhythm is not oversight but the detachment of institutional memory from any single individual; where the party conducting the next review receives, for every question asked, an answer supported by a dated document, its need to insert defensive provisions into the transaction structure diminishes substantially. What is gained is not a point in the negotiation but control over the ground on which the negotiation is conducted.
In an investment-readiness context, what is genuinely being tested here is not whether the ownership structure is simple; a complex cap table is the natural consequence of a multi-round growth history and carries no adverse reading on its own. What is tested is whether the company holds its own complexity in a manageable state — whether future dilution is carried as a predictable variable rather than an emergent one. That distinction is precisely the distinction the reviewing party pursues under nearly every other heading: whether an outcome is attributable to a person or to a mechanism the company can reproduce. The cap table is where the question admits of its cleanest answer, since the distance between assertion and documentation can be measured within a single schedule.
The question worth asking, accordingly, is not what percentage the existing shareholders hold today, but how many people inside the company can state where that percentage lands once every commitment granted has been triggered, by reference to which document, and within what period of time. Where the answer resides in one individual, the cap table is not yet an institutional record but a personal one; and at the diligence table, the difference between those two is invariably priced against the latter.